300194 Fuan Pharmaceutical

Watchlist

4.77
+0.01+0.21%

Market Closed Dec 20 15:00 CST

5.67BMarket Cap20.13P/E (TTM)

About Fuan Pharmaceutical Company

The company was founded on February 25, 2004, and is the first enterprise successfully listed on the Shenzhen GEM in Changshou Economic and Technological Development Zone. It was successfully listed on the Shenzhen Stock Exchange GEM on March 22, 2011. The company is mainly engaged in R&D, production and sales of chemicals. The company's main products are: gentamicin, cefazoxime sodium, cefmetazol sodium, laoxicefin, ceftazidime, torrimifene citrate tablets (preparation), ondansetron hydrochloride (APIs, preparations), doxochylline (active ingredients, preparations), nimegoline capsules, sulinic acid tablets, glutathione. Corporate honors: 2008 - National Key New Products; 2009 - Master's Student Practice Base; 2011 - National Key High-tech Enterprise; 2016 - High-tech Enterprise, “China's Top 100 Pharmaceutical Industry Enterprises” at the National Pharmaceutical Industry Information Annual Conference, “Top 100 Chinese Pharmaceutical R&D Comprehensive Strength” at the 5th China Pharmaceutical R&D Innovation Summit, and “China's Top 50 Chemical Pharmaceutical R&D Capabilities”.

Company Profile

Short Name-A福安药业

Symbol-A300194

Company NameFuan Pharmaceutical (Group) Co.,Ltd.

Listing DateMar 22, 2011

Issue Price41.88

Shares Offered33.40M share(s)

FoundedFeb 25, 2004

Legal Representativetianxiang wang

General Managerlu wang

Secretaryqin tang

Accounting FirmYongtuo Certified Public Accountants (Special General Partnership)

Securities Representativeyadong tao

Legal CounselShanghai Oriental Huayin Law Firm

Employees48

Phone023-61213003

Office AddressNo. 2 Huangyang Road, Yubei District, Chongqing

Zip Code401121

Registered AddressNo.1 Huanan 1st Road, Changshou District, Chongqing

Fax023-68573999

Emailfapharm.@fapharm.com

Websitehttp://www.fapharm.com

Business License500221000008591

BusinessGeneral projects: first-class medical device sales; first-class medical device leasing; health consulting services (excluding diagnosis and treatment services); medical research and experimental development; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; import and export of goods; enterprise management consulting; information consulting services (excluding licensing information consulting services); information technology consulting services; Internet sales (other than selling products requiring a license); technology import and export; enterprise management. (With the exception of projects subject to approval according to law, independent business activities are carried out according to law with a business license) Licensed projects: pharmaceutical wholesale; pharmaceutical retail. (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses)

Company Executives

Name
Position
Salary

tianxiang wang
Chairman, Directors, Chairman of the Strategy Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
919.80K

tao huang
Vice Chairman, Directors, Deputy General Manager
698.70K

xuesong yu
Directors, Deputy General Manager, Chief Financial Officer
608.20K

yong yang
Directors
512.00K

qin tang
Directors, Board Secretary
607.50K

lu wang
Directors, General Manager, Strategy Committee Members
776.20K

zhiqiang liu
Independent Directors, Audit Committee Member, Strategy Committee Member, Chairman of the Nomination Committee
--

zhi dong
Independent Directors, Nomination Committee Members, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
8.30K

geng chen
Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Strategy Committee Members
60.00K